• Posted 02-Nov-2020

The roadmap of improving European healthcare with the help of cell-based medicine

The LifeTime Initiative published its new Strategic Research Agenda that provides a ten-year strategy for the implementation of cell-based interceptive medicine in Europe.

The Strategic Research Agenda of the LifeTime Initiative is a shared vision of more than 100 institutions and medical centres, 80 private companies, patient organisations and European scientific societies.

This research roadmap makes recommendations for investments and research programmes to address main clinical challenges. LifeTime Strategic Research Agenda is a modular strategy document for flexible implementation within existing regional, national and European funding programmes, either as large research initiatives or for smaller, more specific research and innovation programmes, intended at both public and private research funders.

The implementation of the proposed Science and Technology Roadmap will enable to detect and intercept diseases earlier and more efficiently with a cell-based and patient-centred approach and provide effective therapeutic treatments for chronic inflammatory and cardiovascular diseases, neurological conditions and cancer. Applying this approach to key medical challenges will improve the quality of the European citizen’s life and boost the European economy and science.

Source: Digital Single Market News (https://bit.ly/3jMTGbV)